Inicure
TechnologyPipelineWhy InicureAboutNewsPartner with us
Back to news

23 September 2025

Biotech Hanse Stockholm September 2025

CEO Peter Olofsson-Sahl presented Inicure at the #BiotechHanse event as an innovative Swedish life science innovation for Sweden–Germany collaboration and partnership opportunities.

Originally published at inicure.com.

PreviousIMPACT ODINNextLead optimisation support from Scilife DDD

Partnering

Let's advance the next generation of anti-infectives together.

We are actively seeking collaborations and partnerships to advance our development, with the aim of delivering next-generation products in the battle against infections.

Start a partnering conversation

Contact

Peter Olofsson-Sahl

CEO

peter.olofsson-sahl@inicure.com+46 739 01 33 63

Company

Inicure AB
Gothenburg, Sweden
Founded 2024
Spinoff from Pronoxis AB

© 2026 Inicure AB. All rights reserved.

All data described is from preclinical studies.